Review Article | Published:

Lipid raft microdomains and neurotransmitter signalling

Nature Reviews Neuroscience volume 8, pages 128140 (2007) | Download Citation

Subjects

Abstract

Lipid rafts are specialized structures on the plasma membrane that have an altered lipid composition as well as links to the cytoskeleton. It has been proposed that these structures are membrane domains in which neurotransmitter signalling might occur through a clustering of receptors and components of receptor-activated signalling cascades. The localization of these proteins in lipid rafts, which is affected by the cytoskeleton, also influences the potency and efficacy of neurotransmitter receptors and transporters. The effect of lipid rafts on neurotransmitter signalling has also been implicated in neurological and psychiatric diseases.

Key points

  • Lipid rafts are submicroscopic membrane microdomains rich in sphingomyelin and cholesterol.

  • Two common types of lipid raft have been proposed and studied in neurotransmitter signalling: planar lipid rafts (also known as non-caveolar, or glycolipid, rafts) and caveolae.

  • Several classes of neurotransmitter receptors and transporters associate with lipid raft membrane domains and the functional effects of this association are heterogeneous.

  • Lipid rafts are involved in the clustering and trafficking of receptors and transporters, and these rafts seem to be capable of either facilitating or inhibiting neurotransmitter signalling or transport.

  • Cytoskeletal elements such as microtubules or actin microfilaments, and the monomers or dimers that comprise them, associate with lipid rafts and might function to orchestrate neurotransmitter signalling.

  • The localization of signalling components to lipid rafts indicates that molecular events altering this association could contribute to a number of neurological or psychiatric diseases.

  • The heterogeneous action of lipid rafts on neurotransmitter signalling might help to form a uniform hypothesis for the role played by these domains and could help point the way to a mechanism whereby manipulation of rafts generates a pattern of altered information flow.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & The fluid mosaic model of the structure of cell membranes. Science 175, 720–731 (1972).

  2. 2.

    , , & Identifying optimal lipid raft characteristics required to promote nanoscale protein–protein interactions on the plasma membrane. Mol. Cell Biol. 26, 313–323 (2006).

  3. 3.

    & Protein complexes involved in heptahelical receptor-mediated signal transduction. Receptors Channels 9, 169–194 (2003).

  4. 4.

    & Lipid rafts and signal transduction. Nature Rev. Mol. Cell Biol. 1, 31–39 (2000). This review article regarding lipid rafts and signal transduction provides keen insights into lipid raft microdomains and their involvement in cell signalling.

  5. 5.

    , , & Neurological abnormalities in caveolin-1 knock out mice. Behav. Brain Res. 172, 24–32 (2006). Evaluates Cav1 -knockout mice and their associated neurological phenotypes. The results show that the knockout animals develop phenotypes which dictate impaired motor control.

  6. 6.

    et al. Identification of reggie-1 and reggie-2 as plasmamembrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J. Neurobiol. 37, 502–523 (1998).

  7. 7.

    , , , & Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gaq-coupled protein receptors. J. Biol. Chem. 279, 34614–34623 (2004). Utilizes a novel molecular approach to stably knock-down caveolin 1/2 by RNAi in glial cells, resulting in impaired serotonin signalling.

  8. 8.

    et al. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J. 25, 3245–3256 (2006).

  9. 9.

    , & Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts. Traffic 5, 213–230 (2004).

  10. 10.

    , , , & Agrin elicits membrane lipid condensation at sites of acetylcholine receptor clusters in C2C12 myotubes. J. Lipid Res. 47, 2121–2133 (2006).

  11. 11.

    Lipid rafts: contentious only from simplistic standpoints. Nature Rev. Mol. Cell Biol. 7, 456–462 (2006).

  12. 12.

    & Biochemical characterization of detergent-resistant membranes: a systematic approach. Biochem. J. 397, 407–416 (2006).

  13. 13.

    , , , & P2X3 receptor localizes into lipid rafts in neuronal cells. J. Neurosci. Res. 76, 653–661 (2004).

  14. 14.

    , , & The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity. J. Biol. Chem. 279, 356–362 (2004).

  15. 15.

    & Effects of membrane cholesterol on the sensitivity of the GABAA receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology 40, 178–184 (2001).

  16. 16.

    , & Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57, 1577–1592 (2000).

  17. 17.

    , & Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 18, 2954–2961 (1998).

  18. 18.

    , & Assembly of the nicotinic acetylcholine receptor. The first transmembrane domains of truncated α and δ subunits are required for heterodimer formation in vivo. J. Biol. Chem. 271, 27575–27584 (1996).

  19. 19.

    , , & Metabolic cholesterol depletion hinders cell-surface trafficking of the nicotinic acetylcholine receptor. Neuroscience 128, 239–249 (2004).

  20. 20.

    , & Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J. Neurosci. 23, 3262–3271 (2003). These authors demonstrate that, in rat hippocampal neurons, lipid rafts enriched in postsynaptic proteins are abundant in dendrites and are important for maintenance of synaptic morphology and density.

  21. 21.

    & Neuregulin inhibits acetylcholine receptor aggregation in myotubes. J. Biol. Chem. 279, 31622–31628 (2004).

  22. 22.

    , & Membrane lipid rafts are necessary for the maintenance of the α 7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons. J. Neurosci. 21, 504–512 (2001).

  23. 23.

    , & Lipid rafts serve as a signaling platform for nicotinic acetylcholine receptor clustering. J. Neurosci. 26, 4841–4851 (2006). Describes the raft-dependent signalling events involved in the recruitment and anchoring of the AChR into lipid rafts, thereby providing a mechanism for AChR clustering.

  24. 24.

    & Lipid rafts are involved in C95 (4,8) agrin fragment-induced acetylcholine receptor clustering. Neuroscience 138, 123–132 (2006).

  25. 25.

    , , & Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors. J. Neurosci. 19, 6405–6416 (1999).

  26. 26.

    et al. Nicotinic acetylcholine receptor α 7 regulates cAMP signal within lipid rafts. Am. J. Physiol. Cell Physiol. 285, C567–C574 (2003).

  27. 27.

    et al. Coupling of two pools of P2X7 receptors to distinct intracellular signaling pathways in rat submandibular gland. J. Lipid Res. 47, 705–714 (2006).

  28. 28.

    et al. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution. J. Neurochem. 92, 1477–1486 (2005).

  29. 29.

    , , , & Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture. FEBS Lett. 566, 25–29 (2004).

  30. 30.

    , , , & Lipid rafts mediate chemotropic guidance of nerve growth cones. Neuron 42, 51–62 (2004).

  31. 31.

    Membrane organization in G-protein mechanisms. Faseb J. 8, 939–946 (1994).

  32. 32.

    & Cholesterol modulates ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus. Biochim. Biophys. Acta 1663, 188–200 (2004).

  33. 33.

    , , & The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity. J. Biol. Chem. 280, 7135–7146 (2005).

  34. 34.

    et al. Localization of the κ opioid receptor in lipid rafts. J. Pharmacol. Exp. Ther. 317, 1295–1306 (2006).

  35. 35.

    et al. Involvement of caveolin in ligand-induced recruitment and internalization of A1 adenosine receptor and adenosine deaminase in an epithelial cell line. Mol. Pharmacol. 59, 1314–1323 (2001).

  36. 36.

    et al. Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder. Neurochem. Int. 45, 1185–1193 (2004).

  37. 37.

    et al. D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int. 66, 2167–2180 (2004).

  38. 38.

    et al. Metabotropic glutamate type 1α receptor localizes in low-density caveolin-rich plasma membrane fractions. J. Neurochem. 86, 785–791 (2003).

  39. 39.

    et al. Mutual regulation between metabotropic glutamate type 1α receptor and caveolin proteins: from traffick to constitutive activity. Exp. Cell Res. 300, 23–34 (2004).

  40. 40.

    & Lipid rafts and membrane dynamics. J. Cell Sci. 118, 1099–1102 (2005).

  41. 41.

    Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116, 4707–4714 (2003).

  42. 42.

    & Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nature Rev. Mol. Cell Biol. 6, 112–126 (2005).

  43. 43.

    , , & Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and β-arrestin proteins. Prog. Neurobiol. 66, 61–79 (2002).

  44. 44.

    et al. Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates β-1 adrenergic receptor endocytosis through different pathways. J. Biol. Chem. 278, 35403–35411 (2003).

  45. 45.

    & Multiple mechanisms of CB1 cannabinoid receptors regulation. Brain Res. 980, 197–205 (2003).

  46. 46.

    , & Clathrin-independent internalization of the human histamine H1-receptor in CHO-K1 cells. Br. J. Pharmacol. 146, 612–624 (2005).

  47. 47.

    , , & Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J. Biol. Chem. 275, 41447–41457 (2000).

  48. 48.

    , , & β-adrenergic receptor stimulation promotes G αs internalization through lipid rafts: a study in living cells. Mol. Pharmacol. 67, 1493–1504 (2005). Examines the endocytic trafficking of activated β-ARs and Gαs, and find that Gαs is endocytosed by a lipid raft-mediated mechanism leading to a putative reduction in cAMP signalling.

  49. 49.

    , , & Agonist-induced translocation of the kinin B1 receptor to caveolae-related rafts. Mol. Pharmacol. 61, 546–553 (2002).

  50. 50.

    , & Treatment of C6 glioma cells and rats with antidepressant drugs increases the detergent extraction of Gsα from plasma membrane. J. Neurochem. 73, 1114–1120 (1999).

  51. 51.

    , & Signal-dependent translocation of transducin, RGS9–1-Gβ5L complex, and arrestin to detergent-resistant membrane rafts in photoreceptors. Curr. Biol. 12, 421–425 (2002).

  52. 52.

    et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J. Biol. Chem. 280, 31036–31044 (2005).

  53. 53.

    , & Enrichment of G-protein palmitoyltransferase activity in low density membranes: in vitro reconstitution of Gαi to these domains requires palmitoyltransferase activity. J. Biol. Chem. 276, 43300–43304 (2001).

  54. 54.

    , & Lipid-dependent targeting of G proteins into rafts. J. Biol. Chem. 275, 2191–2198 (2000).

  55. 55.

    et al. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270, 15693–15701 (1995).

  56. 56.

    , & Tubulin binds specifically to the signal-transducing proteins, Gs α and Gi α 1. J. Biol. Chem. 265, 1239–1242 (1990).

  57. 57.

    , , & Tubulin, Gq, and phosphatidylinositol 4, 5-bisphosphate interact to regulate phospholipase Cβ1 signaling. J. Biol. Chem. 272, 6760–6765 (1997).

  58. 58.

    , , , & Thyrotropin-releasing hormone-induced depletion of Gqα/G11α proteins from detergent-insensitive membrane domains. FEBS Lett. 464, 35–40 (1999).

  59. 59.

    & Segregation of heterotrimeric G proteins in cell surface microdomains. Gq binds caveolin to concentrate in caveolae, whereas Gi and Gs target lipid rafts by default. Mol. Biol. Cell 12, 685–698 (2001).

  60. 60.

    , & Gs signaling is intact after disruption of lipid rafts. Biochemistry 40, 15418–15423 (2001).

  61. 61.

    et al. Palmitoylation regulates regulators of G-protein signaling (RGS) 16 function. I. Mutation of amino-terminal cysteine residues on RGS16 prevents its targeting to lipid rafts and palmitoylation of an internal cysteine residue. J. Biol. Chem. 278, 19301–19308 (2003).

  62. 62.

    , & Regulation of the Ca2+-inhibitable adenylyl cyclase type VI by capacitative Ca2+ entry requires localization in cholesterol-rich domains. J. Biol. Chem. 275, 26530–26537 (2000).

  63. 63.

    , , , & Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology 139, 2025–2031 (1998).

  64. 64.

    , & Signaling proteins in raft-like microdomains are essential for Ca2+ wave propagation in glial cells. Cell Calcium 14 Aug 2006 (doi:10.1016/j.ceca.2006.06.006).

  65. 65.

    et al. The neural cell adhesion molecule regulates cell-surface delivery of G-protein-activated inwardly rectifying potassium channels via lipid rafts. J. Neurosci. 22, 7154–7164 (2002).

  66. 66.

    et al. Attenuation of G protein-mediated inhibition of N-type calcium currents by expression of caveolins in mammalian NG108-15 cells. J. Physiol. 536, 361–373 (2001).

  67. 67.

    et al. Functional role of lipid raft microdomains in cyclic nucleotide-gated channel activation. Mol. Pharmacol. 65, 503–511 (2004).

  68. 68.

    Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. J. Clin. Psychiatry 64, 5–12 (2003).

  69. 69.

    & Alteration of synaptic membrane cholesterol/phospholipid ratio using a lipid transfer protein. Effect on γ-aminobutyric acid uptake. J. Biol. Chem. 258, 1242–1253 (1983).

  70. 70.

    , & Membrane cholesterol modulates serotonin transporter activity. Biochemistry 40, 10507–10513 (2001).

  71. 71.

    , , , & Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J. Biol. Chem. 279, 38770–38778 (2004).

  72. 72.

    , & Methyl- β-cyclodextrin but not retinoic acid reduces EAAT3-mediated glutamate uptake and increases GTRAP3-18 expression. J. Neurochem. 84, 891–894 (2003).

  73. 73.

    , , & Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. J. Biol. Chem. 279, 34388–34396 (2004).

  74. 74.

    & Cholesterol is required for the reconstruction of the sodium- and chloride-coupled, γ-aminobutyric acid transporter from rat brain. J. Biol. Chem. 265, 6002–6008 (1990).

  75. 75.

    et al. Glial soluble factors regulate the activity and expression of the neuronal glutamate transporter EAAC1: implication of cholesterol. J. Neurochem. 88, 1521–1532 (2004).

  76. 76.

    , & Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization. J. Biol. Chem. 279, 19315–19326 (2004).

  77. 77.

    , , & Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6, 157–170 (2005).

  78. 78.

    , , & A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J. Neurosci. 25, 29–41 (2005).

  79. 79.

    , & Protein tyrosine nitration in rat brain is associated with raft proteins, flotillin-1 and α-tubulin: effect of biological aging. J. Neurochem. 93, 1262–1271 (2005).

  80. 80.

    , , , & Caveolin regulates microtubule polymerization in the vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 342, 164–169 (2006).

  81. 81.

    , , & G protein α subunits activate tubulin GTPase and modulate microtubule polymerization dynamics. J. Biol. Chem. 274, 13485–13490 (1999).

  82. 82.

    , & Microtubule dynamics are necessary for SRC family kinase-dependent growth cone steering. Curr. Biol. 14, 1194–1199 (2004).

  83. 83.

    & PI(4,5)P2-dependent microdomain assemblies capture microtubules to promote and control leading edge motility. J. Cell Biol. 169, 151–165 (2005).

  84. 84.

    & Clathrin-mediated endocytosis of m3 muscarinic receptors. Roles for Gβγ and tubulin. J. Biol. Chem. 279, 30410–30418 (2004).

  85. 85.

    , , , & Tubulin stimulates adenylyl cyclase activity in C6 glioma cells by bypassing the β-adrenergic receptor: a potential mechanism of G protein activation. J. Neurochem. 76, 182–190 (2001).

  86. 86.

    & Chronic antidepressant treatment prevents accumulation of gsα in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts). Neuropsychopharmacology 30, 1238–1245 (2005).

  87. 87.

    et al. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J. Biol. Chem. 281, 26391–26399 (2006). Demonstrates that disrupting either the actin or the microtubule cytoskeleton in cardiac myocytes reduces the number of caveolae and also removes adenylyl cyclase molecules from rafts/caveolae, which enhances cAMP signalling.

  88. 88.

    , & The regulatory subunit of adenylate cyclase interacts with cytoskeletal components. Nature 294, 560–562 (1981).

  89. 89.

    New EMBO members' review: actin cytoskeleton regulation through modulation of PI(4,5)P2 rafts. Embo J. 20, 4332–4336 (2001).

  90. 90.

    & Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453–465 (2003).

  91. 91.

    & Phosphatidylinositol-4, 5-bisphosphate: actin dynamics and the regulation of ATP-dependent and-independent secretion. Mol. Pharmacol. 67, 1089–1098 (2005).

  92. 92.

    , , & H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc. Natl Acad. Sci. USA 102, 15500–15505 (2005).

  93. 93.

    et al. Lipid raft-associated GTPase signaling controls morphology and CD8+ T cell stimulatory capacity of human dendritic cells. J. Immunol. 173, 1628–1639 (2004).

  94. 94.

    et al. Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains. J. Neurosci. 25, 10198–10206 (2005).

  95. 95.

    , , & Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment. Science 219, 65–67 (1983).

  96. 96.

    & G protein signaling and the molecular basis of antidepressant action. Life Sci. 73, 1–17 (2003).

  97. 97.

    , , , & Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113–123 (2003).

  98. 98.

    & The prion protein and lipid rafts. Mol. Membr. Biol. 23, 89–99 (2006).

  99. 99.

    , , & β-Amyloid peptide activates α 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Biol. Chem. 277, 25056–25061 (2002).

  100. 100.

    , , & Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. Am. J. Pathol. 165, 1839–1848 (2004).

  101. 101.

    , , & α-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease. J. Neurochem. 85, 1468–1479 (2003).

  102. 102.

    Lipid rafts at postsynaptic sites: distribution, function and linkage to postsynaptic density. Neurosci. Res. 44, 1–9 (2002).

  103. 103.

    Lipid rafts: elusive or illusive? Cell 115, 377–388 (2003).

  104. 104.

    , & Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem. Sci. 30, 430–436 (2005).

  105. 105.

    & Single-molecule microscopy reveals plasma membrane microdomains created by protein–protein networks that exclude or trap signaling molecules in T cells. Cell 121, 937–950 (2005).

  106. 106.

    & Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68, 533–544 (1992). Determined that, on entering the Golgi complex, GPI-anchored proteins are localized to glycolipid-rich membranes isolated by differential solubility in non-ionic detergents. This work provided the first reported method to isolate detergent-resistant membranes.

  107. 107.

    Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J. Biol. Chem. 271, 9690–9697 (1996). Introduced the non-detergent method of isolating lipid raft/caveolae membranes using sodium carbonate.

  108. 108.

    , & Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 119, 787–796 (2006).

  109. 109.

    , , , & Rapsyn escorts the nicotinic acetylcholine receptor along the exocytic pathway via association with lipid rafts. J. Neurosci. 22, 8891–8901 (2002).

  110. 110.

    et al. Lipid raft localization of GABAA receptor and Na+, K+-ATPase in discrete microdomain clusters in rat cerebellar granule cells. Neurochem. Int. 46, 489–499 (2005).

  111. 111.

    et al. Biochemical evidence for localization of AMPA-type glutamate receptor subunits in the dendritic raft. Brain Res. Mol. Brain Res. 89, 20–28 (2001).

  112. 112.

    & Disruption of lipid rafts inhibits P2X1 receptor-mediated currents and arterial vasoconstriction. J. Biol. Chem. 280, 30705–30711 (2005).

  113. 113.

    , & Caveolin and GLT-1 gene expression is reciprocally regulated in primary astrocytes: association of GLT-1 with non-caveolar lipid rafts. Glia 49, 275–287 (2005).

  114. 114.

    , , & Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. Embo J. 19, 4272–4280 (2000).

  115. 115.

    et al. Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J. Biol. Chem. 276, 42063–42069 (2001).

  116. 116.

    , , , & Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J. Biol. Chem. 280, 12212–12220 (2005).

  117. 117.

    et al. Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers. J. Mol. Neurosci. 26, 177–184 (2005).

  118. 118.

    , & The γ-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J. Neurochem. 79, 787–795 (2001).

  119. 119.

    et al. Ectopically expressed γ-aminobutyric acid receptor B is functionally down-regulated in isolated lipid raft-enriched membranes. Biochem. Biophys. Res. Commun. 321, 981–987 (2004).

  120. 120.

    , & Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol. Pharmacol. 69, 1421–1432 (2006).

  121. 121.

    et al. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler. Thromb. Vasc. Biol. 22, 1267–1272 (2002).

  122. 122.

    et al. Constitutive localization of the gonadotropin-releasing hormone (GnRH) receptor to low density membrane microdomains is necessary for GnRH signaling to ERK. J. Biol. Chem. 278, 31593–31602 (2003).

  123. 123.

    et al. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains. Oncogene 22, 6054–6060 (2003).

  124. 124.

    & Hsp90 interactions and acylation target the G protein Gα 12 but not Gα 13 to lipid rafts. J. Biol. Chem. 277, 32409–32412 (2002).

  125. 125.

    , , & Association of GAP-43 with detergent-resistant membranes requires two palmitoylated cysteine residues. J. Biol. Chem. 273, 28478–28485 (1998).

  126. 126.

    et al. Light- and guanosine 5'-3-O-(thio)triphosphate-sensitive localization of a G protein and its effector on detergent-resistant membrane rafts in rod photoreceptor outer segments. J. Biol. Chem. 276, 20813–20816 (2001).

Download references

Acknowledgements

This work was supported by research grants from the National Institutes of Health to M.M.R and by a National Institutes of Health Training Grant to J.A.A. and R.H. We thank R. Donati for valuable comments about this manuscript.

Author information

Affiliations

  1. Department of Physiology and Biophysics, University of Illinois at Chicago, College of Medicine, Chicago, Illinois, USA.

    • John A. Allen
    • , Robyn A. Halverson-Tamboli
    •  & Mark M. Rasenick
  2. Department of Psychiatry and the Program in Neuroscience, University of Illinois at Chicago, College of Medicine, Chicago, Illinois, USA.

    • Mark M. Rasenick

Authors

  1. Search for John A. Allen in:

  2. Search for Robyn A. Halverson-Tamboli in:

  3. Search for Mark M. Rasenick in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Mark M. Rasenick.

Glossary

Triton X-100

A commonly used non-ionic surfactant detergent that solubilizes proteins and cell membranes.

Sucrose density gradient centrifugation

Separation of cell organelles and subcellular components from crude cellular extracts based on their buoyant density.

P2X purinoreceptor

A plasma membrane channel that is activated by the binding of ATP and is permeant to mono- and divalent cations.

Synaptosome

A preparation of elements of the presynaptic and postsynaptic terminal, isolated after subcellular fractionation. Synaptosomes retain some anatomical integrity and can take up, store and release neurotransmitters.

Heparan sulphate proteoglycans

A group of proteoglycans in which heparan sulphate chains are attached near the cell surface or on extracellular matrix proteins. Agrin is one such proteoglycan, named for its involvement in aggregation of acetylcholine receptors during synaptogenesis.

HEK293 cells

A hypotriploid human cell line derived from embryonic kidney epithelial cells; commonly used as an expression system to study signalling and recombinant proteins.

CHO cells

A chinese hamster ovary cell line often used as an expression system for studying cell signalling and recombinant proteins.

Bmax

A measure of the total number of receptors, determined by the binding of agonist or antagonist ligands. This number will reflect either surface receptors or surface plus internalized receptors depending on the chemical characteristics of the ligand.

RNA interference

(RNAi). A molecular method in which small interfering RNA sequences are introduced into cells or tissues, and subsequently silence the expression of target genes.

C6 glioma cells

A diploid rat cell line cloned from a glial tumour.

Palmitoylation

The covalent attachment of a palmitate (16-carbon saturated fatty acid) to a cysteine residue through a thioester bond.

Myristoylation

The covalent (and, in the case of a G protein, cotranslational) attachment of a hydrophobic myristoyl group to the amino-terminal glycine residue of a nascent polypeptide.

Liposome

A lipid vesicle artificially formed by sonicating lipids in an aqueous solution.

Scaffolding proteins

Proteins that organize groups of interacting intracellular signalling proteins into signalling complexes.

Second messengers

Small intracellular signalling molecules generated in large numbers in response to the primary message of a hormone or neurotransmitter.

Calcium wave

A phenomena by which calcium released from intracellular stores diffuses within a cell in a pattern of waves.

Microtubules

Hollow tubes, 25 nm in diameter, formed by the lateral association of 13 protofilaments which are themselves polymers of α- and β-tubulin subunits.

Colchicine

Alkaloid used to inhibit the polymerization of tubulin and cause the depolymerization of microtubules.

Postsynaptic density

An electron-dense thickening underneath the postsynaptic membrane at excitatory synapses that contains receptors, structural proteins linked to the actin cytoskeleton and signalling elements, such as kinases and phosphatases.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrn2059

Further reading